The value of a Quality Target Product Profile in early development

Clinical trials make up a substantial portion of the overall drug development costs and pharmaceutical companies are intensely focused on ensuring that the trial is well designed and developed. The development of the actual drug product, the Chemistry, Manufacturing and Controls (CMC) section of Investigational Medicinal Products Dossiers (IMPDs) or Investigational New Drug (IND) applications, […] »

Faster access to new and more effective medicines

A long-term collaboration between AstraZeneca and Chalmers led to the founding of InSingulo in 2017. The core business is set up around the challenges of biophysics in drug discovery using single-molecule microscopy. »

PharmaRelations: mapping out what Life Science companies need to grow

Closely followed by successful establishment in Medicon Village in Lund, PharmaRelations is now setting up business at Sahlgrenska Science Park in Gothenburg. This is all part of the long-term strategy; to successfully combines Nordic coverage with local expertise within all areas of Life Science. »